SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-030621
Filing Date
2023-08-30
Accepted
2023-08-30 08:00:55
Documents
162
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form20-f.htm   iXBRL 20-F 3289316
2 ex4-13.htm EX-4.13 175958
3 ex12-01.htm EX-12.01 9438
4 ex12-02.htm EX-12.02 10766
5 ex13-01.htm EX-13.01 5066
6 ex13-02.htm EX-13.02 5174
7 ex15-1.htm EX-15.1 26465
8 ex15-2.htm EX-15.2 1373
9 ex15-3.htm EX-15.3 3519
10 form20-f_001.jpg GRAPHIC 83330
11 ex4-13_001.jpg GRAPHIC 4070
  Complete submission text file 0001493152-23-030621.txt   14935362

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE gene-20230630.xsd EX-101.SCH 130350
13 XBRL CALCULATION FILE gene-20230630_cal.xml EX-101.CAL 118430
14 XBRL DEFINITION FILE gene-20230630_def.xml EX-101.DEF 397687
15 XBRL LABEL FILE gene-20230630_lab.xml EX-101.LAB 653535
16 XBRL PRESENTATION FILE gene-20230630_pre.xml EX-101.PRE 574171
156 EXTRACTED XBRL INSTANCE DOCUMENT form20-f_htm.xml XML 3138808
Mailing Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065
Business Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065 011613-9415-1135
GENETIC TECHNOLOGIES LTD (Filer) CIK: 0001166272 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 000-51504 | Film No.: 231223727
SIC: 2836 Biological Products, (No Diagnostic Substances)